About Uniphar
Uniphar is a company based in Dublin (Ireland) founded in 1967. Uniphar has completed 21 acquisitions, including Angiocare, BESTMSLs and BModesto. Uniphar offers products and services including Uniphar Medtech, Uniphar Pharma, and Supply Chain + Retail.
- Headquarter Dublin, Ireland
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Uniphar Plc
-
Annual Revenue
$2.88 B (USD)8.51as on Dec 31, 2024
-
Net Profit
$66.7 M (USD)43.26as on Dec 31, 2024
-
EBITDA
$124.89 M (USD)6.47as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Angiocare
& 20 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Uniphar
Uniphar is a publicly listed company on the EURONEXT with ticker symbol UPR in Ireland, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Uniphar
Uniphar offers a comprehensive portfolio of products and services, including Uniphar Medtech, Uniphar Pharma, and Supply Chain + Retail.
Distributes medical devices across Europe
Improves access to medicines through services
Manages retail and supply operations for healthcare
People of Uniphar
Unlock access to complete
Funding Insights of Uniphar
Detailed funding history for Uniphar
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Uniphar
Uniphar has strategically engaged in corporate development activities, having acquired 21 companies. Notable acquisitions include Angiocare, BESTMSLs and BModesto.
Investment portfolio details for Uniphar
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diversified drugs are distributed across various markets by BModesto Group.
|
Locked | Locked | 2021 | Locked | |
|
Pharmacy retail, buying and technology company
|
Locked | Locked | 2019 | Locked | |
|
Diversified pharmaceutical drugs are distributed by Orspec Pharma.
|
Locked | Locked | 2019 | Locked |
Complete acquisition details for Uniphar
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Uniphar
Detailed financials for Uniphar
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Uniphar Comparisons
Peer comparison for Uniphar
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Uniphar
Detailed competitors of Uniphar
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Uniphar
Complete news archive for Uniphar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Uniphar
Uniphar was founded in 1967.
Uniphar is headquartered in Dublin, Ireland.
Ger Rabbette is the current CEO of Uniphar.
Annual revenue of Uniphar is $2.88B as on Dec 31, 2024.
Uniphar was established in 1967 in Dublin, Ireland, as a distributor within the pharmaceutical sector. Operations focus on the supply and distribution of speciality drugs to healthcare providers and pharmacies across the region. Services encompass logistics, inventory management, and regulatory compliance for pharmaceutical products. Leadership is provided by CEO Ger Rabbette, ensuring adherence to industry standards in a competitive market.
Uniphar offers Uniphar Medtech, Uniphar Pharma, and Supply Chain + Retail.
Yes, Uniphar is publicly traded on EURONEXT under the ticker symbol UPR.
The ticker symbol of Uniphar is UPR on EURONEXT.